Abstract
Inflammatory bowel diseases have an increased risk of infections due to immunosuppressive therapies. To report the immunization status according to previous recommendations and the reasons explaining a delay, a questionnaire was filled in by the pediatric gastroenterologist, concerning outpatients, in six tertiary centers and five local hospitals, in a study, from May to November 2011. One hundred and sixty-five questionnaires were collected, of which 106 Crohn's diseases, 41 ulcerative colitis, and 17 indeterminate colitis. Sex ratio was 87:78 M/F. Median age was 14.4 years old (4.2–20.0). One hundred and nine patients (66 %) were receiving or had received an immunosuppressive therapy (azathioprine, infliximab, methotrexate, or prednisone). Vaccines were up to date according to the vaccine schedule of French recommendations in 24 % of cases and according to the recommendations for inflammatory bowel disease in 4 % of cases. Coverage by vaccine was the following: diphtheria–tetanus–poliomyelitis 87 %, hepatitis B 38 %, pneumococcus 32 %, and influenza 22 %. Immunization delay causes were as follows: absence of proposal 58 %, patient refusal 41 %, fear of side effects 33 %, and fear of disease activation 5 %. Therefore, immunization coverage is insufficient in children with inflammatory bowel disease, due to simple omission or to refusal. A collaboration with the attending physicians and a targeted information are necessary.
Similar content being viewed by others
References
Beck F., Guilbert P., Gautier A. (dir.) (2007). Baromètre santé 2005 Attitudes et comportements de santé. Saint-Denis, INPES, coll. Baromètres santé, 279–296
Crawford N, Buttery J (2010). Immunizations in an adolescent with inflammatory bowel disease. Paediatrics and Child Health 21:146–147. http://dx.doi.org/10.1016/j.paed.2010.09.007
Crawford NW, Gatto-Smith AG, Oliver MR, Cameron DJ, Buttery JP (2011) An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease. BMC Gastroenterol 11:87
Duricova D, Pedersen N, Elkjaer M, Gamborg M, Munkholm P, Jess T (2010) Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. Inflamm Bowel Dis 16:347–353
Guthmann JP, Fonteneau L, Lévy-Bruhl D (2012). Mesure de la couverture vaccinale en France. Sources de données et données actuelles. Saint-Maurice: Institut de Veille Sanitaire; 98 p. http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies-infectieuses/2012/Mesure-de-la-couverture-vaccinale-en-France
Haut Conseil de Santé Publique (France) (2012). Le calendrier des vaccinations et les recommandations vaccinales 2012 selon l'avis du Haut Conseil de la santé publique. BEH 14–15:161–187. http://www.invs.sante.fr/Publications-et-outils/BEH-Bulletin-epidemiologique-hebdomadaire/Derniers-numeros-et-archives/Archives/2012/BEH-n-14-15-2012
Haut Conseil de Santé Publique (2012). Avis relatif aux recommandations vaccinales spécifiques des personnes immunodéprimées ou aspléniques. http://www.hcsp.fr/docspdf/avisrapports/hcspa20120216_recovaccimmuno.pdf
Lichtenstein GR, Hanauer SB, Sandborn WJ, Practice Parameters Committee of the American College of Gastroenterology (2009) Management of Crohn's disease in adults. Am J Gastroenterol 104:465–483
Melmed GY, Ippoliti AF, Papadakis AK, Tran TT, Birt JL, Lee SK, Frenck RW, Targan SR, Vasiliauskas EA (2006) Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 101:1834–1840
Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N (2009) Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360:1981–1988
Rahier JF, Ben-Horin S, Chowers Y, Conlon C, De Munter P, D'Haens G, Domènech E, Eliakim R, Eser A, Frater J, Gassull M, Giladi M, Kaser A, Lémann M, Moreels T, Moschen A, Pollok R, Reinisch W, Schunter M, Stange EF, Tilg H, Van Assche G, Viget N, Vucelic B, Walsh A, Weiss G, Yazdanpanah Y, Zabana Y, Travis SP, Colombel JF, European Crohn's Colitis Organisation (ECCO) (2009) European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis 3:47–91
Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, Masson P, De Keyser F (2010) Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 49:1815–1827
Rubin GP, Hungin APS, Kelly PJ, Ling J (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 14:1553–1559
Rufo PA, Denson LA, Sylvester FA, Szigethy E, Sathya P, Lu Y, Wahbeh GT, Sena LM, Faubion WA (2012) Health supervision in the management of children and adolescents with inflammatory bowel disease—recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 55(1):93–108
Sands BE, Cuffari C, Katz J, Kugathasan S, Onken J, Vitek C, Orenstein W (2004) Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 10:677–692
Selby L, Hoellein A, Wilson JF (2011) Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients? Dig Dis Sci 56:819–824
Smith C (2006) Vaccination in Australia. Lancet 367:1575
Soons S, deBruyn JC, Wrobel I (2013) Immunization history of children with inflammatory bowel disease. Can J Gastroenterol 27:213–216
Stone MA, Mayberry JF, Baker R (2003) Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England. Eur J Gastroenterol Hepatol 15:1275–1280
Teich N, Klugmann T, Tiedemann A, Holler B, Mössner J, Liebetrau A, Schiefke I (2011) Vaccination coverage in immunosuppressed patients: results of a regional health services research study. Dtsch Arztebl Int 108:105–111
Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ (2008) Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterol 134:929–936
Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF (2008) Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 57:549–558
Wasan SK, Baker SE, Skolnik PR, Farraye FA (2010) A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol 105:1231–1238
Waters O, Ahmad T (2011) Opportunistic infections and vaccinations in IBD patients. J Crohns Colitis 5:263, author reply 264
Wilckens V, Kannengiesser K, Hoxhold K, Frenkel C, Kucharzik T, Maaser C (2011) The immunization status of patients with IBD is alarmingly poor before the introduction of specific guidelines. Scand J Gastroenterol 46:855–861
Yeung JH, Goodman KJ, Fedorak RN (2012) Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients. Inflamm Bowel Dis 18:34–40
Acknowledgments
Jean‐Francois Segura, Laure Bridoux, Gaelle Le Henaff, Benoit Cagnard, Agathe Jobert, Joel Cardonna, Isabelle Grimal, Martine Balençon, Estelle Darviot, Nadege Delaperrière, Dominique Caldari and Hugues Piloquet are responsible for patient screening and enrollment.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Longuet, R., Willot, S., Giniès, JL. et al. Immunization status in children with inflammatory bowel disease. Eur J Pediatr 173, 603–608 (2014). https://doi.org/10.1007/s00431-013-2207-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-013-2207-0